ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metal-Organic Framework-Based Nano-Activators Facilitating Microwave Combined Therapy via a Divide-and-Conquer Tactic for Triple-Negative Breast Cancer

Wu, Qiong; Tan, Longfei*; Ren, Xiangling; Fu, Changhui; Chen, Zengzhen; Ren, Jun; Ma, Tengchuang*; Meng, Xianwei*哈尔滨医科大学
ACS Nano2023-12-14DOI: 10.1021/acsnano.3c09734
10阅读
引用收藏
分享

摘要

Aiming at the clinical problems of high recurrence and metastasis rate of triple-negative breast cancer, a divide-and-conquer tactic is developed. The designed nanoactivators enhance microwave thermo-dynamic-chemotherapy to efficiently kill primary tumors, simultaneously ameliorate the immunosuppressive microenvironment, activate the tumor infiltration of T lymphocytes, and enhance the accumulation and penetration of PD-1/PD-L1 immune agents, ultimately boosting the efficacy of immune checkpoint blocking therapy to achieve efficient inhibition of distal tumors and metastases. Metal-organic framework (MOF)-based MPPT nano-activator is synthesized by packaging chemotherapeutic drug Pyrotinib and immunosuppressant PD-1/PD-L1 inhibitor 2 into MnCa-MOF and then coupling target molecule triphenylphosphine, which significantly improved the accumulation and penetration of Pyrotinib and immunosuppressant in tumors. In addition to the combined treatment of microwave thermo-dynamic-chemotherapy under microwave irradiation, Mn2+ in the nano-activator comprehensively promotes the cGAS-STING pathway to activate innate immunity, microwave therapy, and hypoxia relief are combined to ameliorate the tumor immunosuppressive microenvironment. The released Pyrotinib down-regulates epidermal growth factor receptor and its downstream pathways PI3K/AKT/mTOR and MAPK/ERK signaling pathways to maximize the therapeutic effect of immune checkpoint blocking, which helps to enhance the antitumor efficacy and promote long-term memory immunity. This nano-activator offers a generally promising paradigm for existing clinical triple-negative breast cancer treatment through a divide-and-conquer strategy.

学科与关键词

关键词
triple-negative breast cancernano-activatormicrowave combined therapyimmunotherapycGAS-STING
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
ACS Nano
发表日期
2023-12-14
卷期
第 17 卷, 第 24 期
页码
25575-25590
DOI
10.1021/acsnano.3c09734
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [JQ23035, 4222019]; Beijing Natural Science Foundation [62001456, U20A20335, 82172041, 81801808]; National Natural Science Foundation of China [YQ2023H023]; Natural Science Foundation of Heilongjiang

作者

  • W

    Wu, Qiong (第一作者)

    chinese acad sci, tech inst phys & chem

  • T

    Tan, Longfei (通讯)

    chinese acad sci, tech inst phys & chem

查看全部 8 位作者收起作者
  • R

    Ren, Xiangling

    chinese acad sci, tech inst phys & chem

  • F

    Fu, Changhui

    chinese acad sci, tech inst phys & chem

  • C

    Chen, Zengzhen

    chinese acad sci, tech inst phys & chem

  • R

    Ren, Jun

    chinese acad sci, tech inst phys & chem

  • M

    Ma, Tengchuang (通讯)

    harbin med univ

  • M

    Meng, Xianwei (通讯)

    chinese acad sci, tech inst phys & chem

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417